Accelerated kindling development in μ-opioid receptor deficient mice

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 3, 2004, Pages 287-293

  Grecksch, G ^a   Becker, A ^a   Schroeder, H ^a   Kraus, J ^a   Loh, H ^b   Hollt V ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

Opioid receptor; Chemical kindling; Receptor binding; Shuttle box learning; Transgenic mice

Indexed keywords

DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; PENTETRAZOLE; SOMATOSTATIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; GENOTYPE; KINDLING; KNOCKOUT MOUSE; LEARNING; LEARNING DISORDER; MALE; MOUSE; NONHUMAN; RECEPTOR BINDING; SEIZURE;

ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; KINDLING, NEUROLOGIC; MALE; MICE; MICE, KNOCKOUT; PENTYLENETETRAZOLE; PROTEIN BINDING; RECEPTORS, OPIOID, MU;

EID: 1642395055     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0870-4     Document Type: Article

References (50)

1. Ahmad I, Pleuvry BJ (1995) Interactions between opioid drugs and propofol in laboratory models of seizures. Br J Anaesth 74:311-314
2. Becker A, Grecksch G, Rüthrich HL, Pohle W, Marx B, Matthies H (1992) Kindling and its consequences on learning in rats. Behav Neural Biol 57:37-43
3. Becker A, Grecksch G, Brosz M (1994). Naloxone ameliorates the learning deficit induced by pentylenetetrazol kindling in rats. Eur J Neurosci 6:1512-1515
4. Becker A, Braun H, Schröder H, Grecksch G, Höllt V (1999) Effects of enadoline on the development of pentylenetetrazol kindling, learning performance, and hippocampal morphology. Brain Res 823:191-197
5. Becker A, Grecksch G, Brödemann R, Kraus J, Peters B, Schroeder H, Thiemann W, Loh HH, Höllt V (2000) Morphine self-administration in μ-opioid receptor-deficient mice. Naunyn-Schmiedebergs Arch Pharmacol 361:584-589
6. Braun H, Schulz S, Becker A, Schröder H, Höllt V (1998) Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Res 803:54-60
7. Cain DP, Corcoran ME (1984) Intracerebral beta-endorphin, metenkephalin and morphine: kindling of seizures and handling-induced potentiation of epileptiform effects. Life Sci 34:2535-2542
8. Cain DP, Corcoran ME (1985) Epileptiform effects of metenkephalin, beta-endorphin and morphine: kindling of generalized seizures and potentiation of epileptiform effects by handling. Brain Res 338:327-336
9. Cain DP, Boon F, Corcoran ME (1990) Involvement of multiple opiate receptors in opioid kindling. Brain Res 517:236-244
10. Chen H, Seybold VS, Loh HH (2000) An autoradiographic study in mu-opioid receptor knockout mice. Brain Res Mol Brain Res 76:170-172
11. Cogswell C (1852) On the local action of poisons. Lancet 2:488-490
12. Erdtmann-Vourliotis M, Riechert U, Mayer P, Grecksch G, Höllt V (1998) Pentylenetetrazole (PTZ)-induced c-fos expression in the hippocampus of kindled rats is suppressed by concomitant treatment with naloxone. Brain Res 792:299-308
13. Frenk H (1983) Pro- and anticonvulsant actions of morphine and endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res Rev 6:197-210
14. Frenk H, Urea G, Liebeskind JC (1978) Epileptic properties of leucine- and methionine-enkephalin: comparison with morphine and reversibility by naloxone. Brain Res 147:327-337
15. Goddard GV (1982) Separate analysis of lasting alteration in excitatory synapses, inhibitory synapses and cellular excitability in association with kindling. Electroencephalogr Clin Neurophysiol Suppl 36:288-294
16. Grecksch G, Becker A, Schroeder H, Höllt V (1999) Involvement of delta-opioid receptors in pentylenetetrazol kindling development and kindling-related processes in rats. Naunyn-Schmiedebergs Arch Pharmacol 360:151-156
17. Ito T, Hori M, Yoshida K, Shimizu M (1977) Effect of anticonvulsants on seizures developing in the course of daily administration of pentetrazol to rats. Eur J Pharmacol 45:165-172
18. Jamot L, Matthes HW, Simonin F, Kieffer BL, Roder JC (2003) Differential involvement of the mu and kappa opioid receptors in spatial learning. Genes Brain Behav 2:80-92
19. Jang CG, Lee SY, Loh HH, Ho IK (2001) Lack of mu-opioid receptor leads to an increase in the NMDA receptor subunit mRNA expression and NMDA-induced convulsion. Brain Res Mol Brain Res 94:105-111
20. Kalyuzhny AE, Dooyema J, Wessendorf MW (2000) Opioid- and GABA(A)-receptors are co-expressed by neurons in rat brain. Neuroreport 11:2625-2628
21. Kitchen I, Slowe SJ, Matthes HW, Kieffer B (1997) Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 778:73-88
22. LaBuda CJ, Sora I, Uhl GR, Fuchs PN (2000) Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system. Brain Res 869:1-5
23. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN (1998) mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54:321-326
24. Mason CR, Cooper RM (1972) A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol. Epilepsia 13:663-674
25. Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubie M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL (1998) Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappareceptor is maintained in mice lacking the mu-receptor. J Neurosci 18:7285-7295
26. Matthies H, Schroeder H, Becker A, Loh H, Höllt V, Krug M (2000) Lack of expression of long-term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioid receptor-deficient mice. Neuropharmacology 39:952-960
27. Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, Carlo AS, Viollet C, Hannon JP, Fehlmann D, Nunn C, Hoyer D, Epelbaum J, Vezzani A (2002) Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci 16:843-849
28. Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL, Beaudet A (2003) Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23:4888-4898
29. Park Y, Ma T, Tanaka S, Jang C, Loh HH, Ko KH, Ho IK (2000) Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice. Brain Res Bull 52:297-302
30. Park Y, Jang CG, Yang KH, Loh HH, Ma T, Ho IK (2003) Re-gional specific increases of [3H]AMPA binding and mRNA expression of AMPA receptors in the brain of mu-opioid re-ceptor knockout mice. Brain Res Mol Brain Res 113:116-123
31. Pfeiffer M, Koch T, Schröder H, Laugsch M, Hölt V, Schulz S (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 277:19762-19772
32. Rocha L, Tatsukawa K, Chugani HAT, Engel J Jr (1993) Benzodi-azepine receptor binding following chronic treatment with naloxone, morphine and met-enkephalin in normal rats. Brain Res 612:247-252
33. Rocha L, Briones M, Ackermann RF, Anton B, Maidment NT, Evans CJ, Engel J Jr (1996) Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Res 26:105-113
34. Rocha L, Maidment NT, Evans CJ, Ackermann RF, Engel J Jr (1996) Opioid peptide release and mu-receptor binding during amygdala kindling in rats: regional discordances. Epilepsy Res Suppl 12:215-228
35. Rocha L, Cano A, Cruz C, Omana-Zapata I, Villalobos R, Maidment NT (1999) Opioid peptide systems following a subconvulsant dose of pentylenetetrazol in rats. Epilepsy Res 37:141-150
36. Rostampour M, Fathollahi Y, Semnanian S, Hajizadeh S, Mirnajafizadeh J, Shafizadeh M (2002) Cysteamine pre-treatment reduces pentylenetetrazol-induced plasticity and epileptiform discharge in the CA1 region of rat hippocampal slices. Brain Res 955:98-103
37. Sander T, Berlin W, Gscheidel N, Wendel B, Janz D, Hoehe MR (2000) Genetic variation of the human mu-opioid receptor and susceptibility to idiopathic absence epilepsy. Epilepsy Res 39:57-61
38. Sasaki K, Fan L-W, Tien L-T, Ma T, Loh HH, Ho IK (2002) The interaction of morphine and γ-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using (μ-opioid receptor knock-out mice. Brain Res Bull 57:689-694
39. Schroeder H, Becker A, Grecksch G, Schroeder U, Hoellt V (1998) The effect of pentylenetetrazol kindling on synaptic mechanisms of interacting glutamatergic and opioid system in the hippocampus of rats. Brain Res 811:40-46
40. Schroeder H, Becker A, Schroeder U, Hoellt V (1999) 3H-L-glutamate binding and 3H-D-aspartate release from hippocampal tissue during the development of pentylenetetrazole kindling in rats. Pharmacol Biochem Behav 62:349-352
41. Simmons ML, Chavkin C (1996) Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 39:145-196
42. Skyers PS, Einheber S, Pierce JP, Milner TA (2003) Increased muopioid receptor labeling is found on inner molecular layer terminals of the dentate gyms following seizures. Exp Neurol 179:200-209
43. Sora I, Funada M, Uhl GR (1997) The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia. Eur J Pharmacol 124:R1-R2
44. Urea G, Frenk H, Liebeskind JC, Taylor AN (1977) Morphine and enkephalin: analgesic and epileptic properties. Science 197:83-86
45. Vezzani A, Hoyer D (1999) Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. Eur J Neurosci 11:3767-3776
46. Vindrola O, Briones R, Asai M, Fernandez-Guardiola A (1981) Brain content of leu5- and met5-enkephalin changes independently during the development of kindling in the rat. Neurosci Lett 26:125-130
47. Vindrola O, Asai M, Zubieta M, Linares G (1983) Brain content of immunoreactive [Leu5]enkephalin and [Met5]enkephalin after pentylenetetrazol- induced convulsions. Eur J Pharmacol 90:85-89
48. Voigt JP, Morgenstern E (1990) Pentylenetetrazole kindling impairs learning in mice. Biomed Biochim Acta 49:143-145
49. Yukhananov RY, Larson AA (1994) Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: short-term effects on N-methyl-D-aspartate (NMDA) and long-term effects on kainic acid. Brain Res 646:194-200
50. Zukin SR, Young AB, Snyder SH (1974) Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci USA 71:4802-4807